We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSBC icon
2276
Great Southern Bancorp
GSBC
$863M
$7K ﹤0.01%
143
HTBK
2277
DELISTED
Heritage Commerce
HTBK
$7K ﹤0.01%
795
NFBK
2278
DELISTED
Northfield Bancorp
NFBK
$7K ﹤0.01%
586
NVO
2279
Novo Nordisk
NVO
$216B
$7K ﹤0.01%
208
-34
-14% -$1.18K
QCRH icon
2280
QCR Holdings
QCRH
$1.65B
$7K ﹤0.01%
189
ICHR icon
2281
Ichor Holdings
ICHR
$3.02B
$6K ﹤0.01%
200
MBI icon
2282
MBIA
MBI
$288M
$6K ﹤0.01%
972
CFB
2283
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$6K ﹤0.01%
555
ORAN
2284
DELISTED
Orange
ORAN
$6K ﹤0.01%
533
+108
+25% +$1.26K
NWLI
2285
DELISTED
National Western Life Group, Inc. Class A
NWLI
$6K ﹤0.01%
31
RLMD icon
2286
Relmada Therapeutics
RLMD
$544M
$5K ﹤0.01%
171
MTEM
2287
DELISTED
Molecular Templates, Inc.
MTEM
$5K ﹤0.01%
39
SAP icon
2288
SAP
SAP
$187B
$4K ﹤0.01%
+33
New +$4.26K
TCDA
2289
DELISTED
Tricida, Inc. Common Stock
TCDA
$4K ﹤0.01%
537
AE
2290
DELISTED
Adams Resources & Energy Inc
AE
$3K ﹤0.01%
130
EEM icon
2291
iShares MSCI Emerging Markets ETF
EEM
$28B
$2K ﹤0.01%
31
-53
-63% -$2.55K
LEGN icon
2292
Legend Biotech
LEGN
$4.3B
$2K ﹤0.01%
67
+1
+2% +$29
ALR
2293
DELISTED
AlerisLife Inc
ALR
$2K ﹤0.01%
361
-4,636
-93% -$26.9K
APRE icon
2294
Aprea Therapeutics
APRE
$7.83M
$1K ﹤0.01%
14
AGI icon
2295
Alamos Gold
AGI
$12.4B
-4,307
Closed -$38K
AMWL icon
2296
American Well
AMWL
$181M
-375
Closed -$222K
AOUT icon
2297
American Outdoor Brands
AOUT
$162M
-270
Closed -$4K
LONA
2298
LeonaBio Inc
LONA
$69.4M
-500
Closed -$92K
AVAL icon
2299
Grupo Aval
AVAL
$5.67B
-52,340
Closed -$242K
BEPC icon
2300
Brookfield Renewable
BEPC
$6.12B
-1,539
Closed -$60K

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.